In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms (Q42982898)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 February 2004

Language	Label	Description	Also known as
English	In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms	scientific article published on 6 February 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Chao Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kai Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yu-Ping Luong

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

B Govinda Rao

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yun-Yi Wei

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Debra L Brennan

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

John R Fulghum

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hsun-Mei Hsiao

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sue Ma

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

John P Maxwell

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kevin M Cottrell

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Robert B Perni

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Cynthia A Gates

13

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ann D Kwong

14

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

6 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

279

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

17508-17514

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Epidemiology of hepatitis C: geographic differences and temporal trends

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Efficient initiation of HCV RNA replication in cell culture

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

In Vitro Selection and Characterization of Hepatitis C Virus Serine Protease Variants Resistant to an Active-Site Peptide Inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Resistance Profile of a Hepatitis C Virus RNA-Dependent RNA Polymerase Benzothiadiazine Inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313020200

21 January 2018

Identifiers

10.1074/JBC.M313020200

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42982898&oldid=1975840290"